Protein Science Sheba protein
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print July 28, 2008
Protein Science, DOI: 10.1110/ps.036590.108
Copyright © 2008 The Protein Society
ACCEPTED PREPRINT
This Article
ACCEPTED PREPRINT
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.036590.108v1
17/10/1791    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Zhao, B.
Right arrow Articles by Lai, Z.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, B.
Right arrow Articles by Lai, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Modulation of Kinase-Inhibitor Interactions by Auxiliary Protein Binding: Crystallography Studies on Aurora A Interactions with VX-680 and with TPX2

Baoguang Zhao, Angela Smallwood, Jingsong Yang, Kristin Koretke, Kelvin Nurse, Amy Calamari, Robert B Kirkpatrick, and Zhihong Lai1

GlaxoSmithKline

(RECEIVED May 21, 2008; ACCEPTED July 22, 2008)

VX-680, also known as MK-0457, is an ATP-competitive small molecule inhibitor of the Aurora kinases that has entered phase II clinical trials for the treatment of cancer. We have solved the co-crystal structure of AurA/TPX2/VX-680 at 2.3 Å resolution. In the crystal structure, VX-680 binds to the active conformation of Aur A. The glycine-rich loop in AurA adopts a unique bent conformation, forming a {pi}-{pi} interaction with the phenyl group of VX-680. In contrast, in the published AurA/VX-680 structure, VX-680 binds to AurA in the inactive conformation, interacting with a hydrophobic pocket only present in the inactive conformation. These data suggest that TPX2, a protein cofactor, can alter the binding mode of VX-680 with AurA. More generally, the presence of physiologically-relevant cofactor proteins can alter the kinetics, binding interactions, and inhibition of enzymes, and studies with these multi-protein complexes may be beneficial to discovery and optimization of enzyme inhibitors as therapeutic agents.

Keywords: Conformational changes; Enzymes; Active sites; Structure; Crystallography; Protein crystallization; Enzyme Inhibitors


1 E-mail: zhihong.v.lai{at}gsk.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by The Protein Society.